Tag Archives: Blood Cells

Cancer Research, Immuno-Oncology, Immunotherapy, Immunotherapy for Cancer

New Smart Blood Test Allows Doctors to Tailor Treatment

New Smart Blood Test Allows Doctors to Tailor Treatment
New Smart Blood Test Allows Doctors to Tailor Treatment

One of the challenges doctors face in treating cancer is the difficulty of determining the most effective treatment protocols for each patient. Researchers are optimistic that liquid biopsies, or “smart blood tests,” will help match patients with appropriate therapies.

Using DNA Tracking for Individualized Treatment

At our Issels® center, immunotherapy for cancer is tailored to a patient’s specific case, including location of the tumor and its microenvironment. Liquid biopsies track cancer DNA, enabling doctors to customize a patient’s treatment and monitor progress.

Blood tests are minimally invasive, so patients could undergo the process frequently with no ill effects. Doctors can then track changes more accurately over time and determine whether treatment should be changed or modified.

Liquid Blood Tests Undergo Groundbreaking Trial

This fall, scientists from the Institute of Cancer Research in London will launch the plasmaMATCH trial with 1,000 breast cancer patients. Breast cancer makes a good test subject due to its propensity to mutate as a defense against treatment.

If the trial results are encouraging, experts hope that liquid biopsies will become a standard element of cancer care within the next two years. According to Professor Johann de Bono of the Institute of Cancer Research, smart blood tests could lead to major changes in cancer screening and risk assessment with the general public.

Personally Tailored Immunotherapy for Cancer at Issels®

Our non-toxic immunotherapy protocols are based on a patient’s particular tumor and microenvironment, as well as personal factors such as lifestyle and genetic predispositions. Contact us for more information, including testimonials from patients with all forms of cancer.

 

Alternative Cancer Treatment

Issels – Why Mexico?

Innovation In Cancer
Innovation In Cancer

Every year, over one million Americans are diagnosed with cancer. Of those diagnosed, studies suggest 60 percent turn to alternative cancer therapy in conjunction with or in lieu of conventional treatment, discovering a large number of these alternative facilities are located outside of the country, such as Mexico.

Why not the U.S.?
In the past, many clinics outside the U.S. were not taken very seriously, however those times have drastically changed. Because conventional forms of cancer care such as surgery, chemo and radiation are the only forms of therapy covered by the U.S. healthcare system and insurance companies, many doctors choose to practice in Mexico in order to offer a broader array of treatments from around the world – and at a more affordable price. Over 500,000 estimated cancer patients leave the U.S. for treatment annually seeking these highly successful treatments.

Why seek alternative treatment?
Integrative approaches to cancer treatment provide individualized regimens tailored specifically for each individual. They focus on healing the entire body, with the added benefits of fewer side effects and improved quality of life when combined with conventional therapies such as chemotherapy and radiation. Natural cancer therapies are also sought, offering hope, when conventional treatments fail.

How accepted are the alternatives?
For over a decade, complementary and alternative cancer treatments have been gaining acceptance, resulting in the creation of such organizations as the National Cancer Institute’s Office of Cancer Complementary and Alternative Medicine (CAM). In fact, Cancer.gov, the National Cancer Institute’s website, acknowledges the evaluation of certain CAM therapies and their capability to help patients feel better and recover faster.

Looking for a safer, more effective cancer treatment option? Contact Issels today.

Alternative Cancer Treatment, Cancer Research

White Blood Cells May Aid Cancer Spread

1 Comment
New Cancer Cancer Studies
New Cancer Studies

One of the stalwarts of the body’s immune system may actually aid the spread of cancer cells, according to a new Canadian study. White blood cells, or leukocytes, are immune system responders that defend the body against infectious disease and foreign substances. Produced in bone marrow, five distinct types of white blood cells circulate throughout the human body, including in the blood and lymphatic systems.

One way in which white blood cells protect the body from infection is by forming defensive DNA “webs” called Neutrophils Extracellular Traps. These webs trap harmful pathogens, but scientists at the Research Institute of the McGill University Health Centre in Montreal, Canada found that they also trap cancer cells circulating in the body, causing them to activate; thereby increasing the opportunity for cancer to metastasize and spread.

Perhaps more hopeful, researchers also found that disrupting the DNA web can halt the growth and spread of cancer, offering new cancer treatment avenues to explore. The first research to discover this method of cancer metastasis, findings were published in the Journal of Clinical Investigation and could jump start new immunotherapy cancer treatments.

In an announcement, lead researcher Dr. Lorenzo Ferri,  MUHC director of Thoracic Surgery and the Upper Gastrointestinal Cancer Program, said:

“Medications already exist that are being used for other non-cancer diseases, which may prevent this mechanism of cancer spread or metastasis.”

Issels Integrative Oncology has more than 60 years of proven experience using advanced immunotherapy protocols to treat and arrest advanced forms of cancer. Visit our website to find out more about our cell therapies, gene-targeted therapies, cancer vaccines and other alternative cancer treatments.